{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T17:51:01Z","timestamp":1777053061183,"version":"3.51.4"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006578","name":"Chi Mei Medical Center","doi-asserted-by":"publisher","award":["CMNDMC11014"],"award-info":[{"award-number":["CMNDMC11014"]}],"id":[{"id":"10.13039\/501100006578","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>COVID-19 infection has been associated with cardiovascular complications, including new-onset atrial fibrillation\/flutter (NOAF). However, the potential protective effect of COVID-19 vaccination against long-term NOAF risk following COVID-19 infection remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study used the TriNetX Research Network to identify adults diagnosed with COVID-19. Patients were divided into a vaccine group and control group (unvaccinated). After propensity score matching (238,750 patients per group), we assessed the primary outcome of 24-month NOAF incidence, with secondary outcomes at 1, 6 and 12 months. Subgroup analyses examined effects across patient characteristics and comorbidities. Sensitivity analysis was performed by excluding patients with severe COVID-19 illness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The 24-month NOAF incidence was significantly lower in the vaccine group compared to the control group (1.91% vs 2.18%; HR: 0.82, 95% CI: 0.78\u20130.85). This protective effect was also observed at 1 month (HR: 0.73, p\u2009&lt;\u20090.001), 6 months (HR: 0.71, p\u2009&lt;\u20090.001), and 12 months (HR: 0.77, p\u2009&lt;\u20090.001). Sensitivity analysis confirmed these findings (HR: 0.79 at 24 months). Subgroup analyses demonstrated that COVID-19 vaccination provided significant protection against NOAF across all examined subgroups, with younger patients (18\u201360 years) showing greater risk reduction compared to older individuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>COVID-19 vaccination was associated with a significantly reduced 24-month risk of NOAF after COVID-19 infection. These findings suggest vaccination may mitigate long-term cardiovascular sequelae of COVID-19. Future research should elucidate underlying protective mechanisms and optimize vaccination strategies for cardiovascular protection, particularly in high-risk populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0348133","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T17:33:25Z","timestamp":1777052005000},"page":"e0348133","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["The impact of COVID-19 vaccination on long-term risk of new-onset atrial fibrillation\/flutter after COVID-19 infection: A retrospective cohort study"],"prefix":"10.1371","volume":"21","author":[{"given":"Ching-Chung","family":"Ko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jheng-Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Chuan","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Wei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Wen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsung","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Ming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7122-6901","authenticated-orcid":true,"given":"I-Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"issue":"4","key":"pone.0348133.ref001","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s10741-021-10129-2","article-title":"Clinical variants of myocardial involvement in COVID-19-positive patients: a cumulative experience of 2020","volume":"27","author":"M Guglin","year":"2022","journal-title":"Heart Fail Rev"},{"issue":"7","key":"pone.0348133.ref002","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.ajem.2020.04.048","article-title":"Cardiovascular complications in COVID-19","volume":"38","author":"B Long","year":"2020","journal-title":"Am J Emerg Med"},{"issue":"5","key":"pone.0348133.ref003","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3390\/jcm9051407","article-title":"Impact of COVID-19 on the Cardiovascular System: A Review","volume":"9","author":"K Matsushita","year":"2020","journal-title":"J Clin Med"},{"issue":"2","key":"pone.0348133.ref004","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10840-020-00789-9","article-title":"COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies","volume":"59","author":"R Gopinathannair","year":"2020","journal-title":"J Interv Card Electrophysiol"},{"issue":"19","key":"pone.0348133.ref005","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/eurheartj\/ehaa388","article-title":"Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy","volume":"41","author":"RM Inciardi","year":"2020","journal-title":"Eur Heart J"},{"issue":"9","key":"pone.0348133.ref006","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.jacep.2021.02.009","article-title":"Atrial Fibrillation in Patients Hospitalized With COVID-19: Incidence, Predictors, Outcomes, and Comparison to Influenza","volume":"7","author":"DR Musikantow","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"issue":"11","key":"pone.0348133.ref007","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/jcm10112490","article-title":"Prevalence and Impact of Atrial Fibrillation in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis","volume":"10","author":"GF Romiti","year":"2021","journal-title":"J Clin Med"},{"issue":"9","key":"pone.0348133.ref008","doi-asserted-by":"crossref","first-page":"11347","DOI":"10.1096\/fj.202001613","article-title":"Atrial fibrillation in COVID-19: A review of possible mechanisms","volume":"34","author":"E Stone","year":"2020","journal-title":"FASEB J"},{"issue":"5","key":"pone.0348133.ref009","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5492\/wjccm.v12.i5.236","article-title":"New-onset atrial fibrillation among COVID-19 patients: A narrative review","volume":"12","author":"F Talaei","year":"2023","journal-title":"World J Crit Care Med"},{"issue":"6","key":"pone.0348133.ref010","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e17199","article-title":"Effect of atrial fibrillation on mortality in SARS-CoV-2 patients: A propensity score-matched analysis of nationwide hospitalizations in the United States","volume":"9","author":"D Antwi-Amoabeng","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"pone.0348133.ref011","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/s12872-024-04086-5","article-title":"Complications of new-onset atrial fibrillation in critically ill COVID-19 patients admitted to the intensive care unit (ICU): a meta-analysis","volume":"24","author":"T Zhang","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"pone.0348133.ref012","doi-asserted-by":"crossref","first-page":"34","DOI":"10.5603\/CJ.a2020.0145","article-title":"New-onset atrial fibrillation during COVID-19 infection predicts poor prognosis","volume":"28","author":"A Pardo Sanz","year":"2021","journal-title":"Cardiol J"},{"issue":"9","key":"pone.0348133.ref013","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.hrthm.2024.04.064","article-title":"Risk of incident atrial fibrillation after COVID-19 infection: A systematic review and meta-analysis","volume":"21","author":"M Zuin","year":"2024","journal-title":"Heart Rhythm"},{"key":"pone.0348133.ref014","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.coi.2021.07.003","article-title":"COVID-19 vaccines","volume":"71","author":"D Ndwandwe","year":"2021","journal-title":"Current Opinion in Immunology"},{"issue":"1","key":"pone.0348133.ref015","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2507","article-title":"Safety and efficacy of COVID-19 vaccines: A systematic review and meta-analysis of controlled and randomized clinical trials","volume":"34","author":"J Beladiya","year":"2024","journal-title":"Rev Med Virol"},{"key":"pone.0348133.ref016","doi-asserted-by":"crossref","first-page":"714170","DOI":"10.3389\/fimmu.2021.714170","article-title":"Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis","volume":"12","author":"N Sharif","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"pone.0348133.ref017","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/s41591-022-01699-1","article-title":"Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England","volume":"28","author":"N Andrews","year":"2022","journal-title":"Nat Med"},{"key":"pone.0348133.ref018","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbi.2023.03.022","article-title":"COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis","volume":"111","author":"F Ceban","year":"2023","journal-title":"Brain Behav Immun"},{"issue":"11","key":"pone.0348133.ref019","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.vaccine.2023.02.008","article-title":"Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis","volume":"41","author":"A Watanabe","year":"2023","journal-title":"Vaccine"},{"issue":"5","key":"pone.0348133.ref020","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0002-9343(02)01236-6","article-title":"A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew\/Paisley study","volume":"113","author":"S Stewart","year":"2002","journal-title":"Am J Med"},{"issue":"14","key":"pone.0348133.ref021","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1177\/2047487317715769","article-title":"Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis","volume":"24","author":"V Ruddox","year":"2017","journal-title":"Eur J Prev Cardiol"},{"issue":"5","key":"pone.0348133.ref022","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00217.2020","article-title":"COVID-19, ACE2, and the cardiovascular consequences","volume":"318","author":"AM South","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"pone.0348133.ref023","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s13054-016-1440-0","article-title":"The right ventricle: interaction with the pulmonary circulation","volume":"20","author":"MR Pinsky","year":"2016","journal-title":"Crit Care"},{"issue":"12","key":"pone.0348133.ref024","first-page":"2057","article-title":"Effect of Vaccination against SARS-CoV-2 on Long COVID-19: A Narrative Review","volume":"12","author":"AG Tofarides","year":"2022","journal-title":"Life (Basel)"},{"key":"pone.0348133.ref025","doi-asserted-by":"crossref","first-page":"101624","DOI":"10.1016\/j.eclinm.2022.101624","article-title":"Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review","volume":"53","author":"KI Notarte","year":"2022","journal-title":"EClinicalMedicine"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0348133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T17:33:30Z","timestamp":1777052010000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0348133"}},"subtitle":[],"editor":[{"given":"Alessandro","family":"Cannavo","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0348133","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]}}}